The journey to discovery is guided by science
Our areas of focus
Oncology
Our teams of researchers and scientists are pushing the boundaries of cancer research to discover more effective anticancer therapies.
We’re working to create a world where cancer isn’t just treated but cured. We’re advancing one of the most diverse and differentiated oncology pipelines, attacking cancer from multiple angles. Over the past decade, our research has rewritten medical textbooks on how cancer is treated while helping to extend and improve the lives of millions of people.
Neuroscience
We're tackling the complexities and therapeutic challenges of some of the most devastating neurological disorders. We’re advancing research to tackle the complexities of some of the most devastating nervous system disorders in an effort to develop medicines that may treat, slow progression or prevent these diseases. Neuroscience is evolving. New powerful imaging technologies and insights from human genetics and cell biology are helping us better understand disease-related changes in the brain and the nervous system. These rapidly emerging insights are enabling the development of new approaches to treating devastating diseases of the nervous system.
Immunology
We're at the forefront of research, seeking to translate scientific discoveries into treatments for people with immune-mediated inflammatory disorders. We aspire to be a leader in immunology. Our scientists are applying their expertise to the discovery and development of therapies to alleviate the burden of immune-mediated inflammatory diseases. We’re thinking strategically about how we can elevate the standards of care in key disease areas by identifying novel targets, combining targets and investigating precision medicine. We’re accelerating our growing capabilities in immunology and evaluating new treatment options for people with certain immune disorders.
Real-world data & evidence
We leverage real-world data, evidence and insights and real-time environmental measures to ensure safe and effective use of our medicines and vaccines.
Our data science community spans every therapeutic area, and at every level in R&D, we’re building scalable data platforms to speed up innovation and bring more life-changing medicines to patients. We see the potential of data science, AI and ML to help investigate new areas, pathways and mechanisms that may forge new opportunities as we continue replenishing our pipeline through enhanced insights.
Areas of innovation
We’re harnessing new tools, techniques and technologies to accelerate our pipeline and deliver transformative medicines and vaccines to patients. We’ve been using data science, artificial intelligence (AI) and machine learning (ML) to help overcome bottlenecks in discovery, research and development .
Technology & Our Research Philosophy
Our capabilities span the development of differentiated products including liposomal delivery, inhalers, lyophilised injections, nasal sprays besides developing controlled and modified release dosage forms. We are also pioneers in delivery systems of ophthalmology, cardiology, peptides, CNS and oncology. Our knowledge in pharmaceutical research allows a rapid ramp-up of a diverse range of immediate and Novel Delivery Systems spanning oral, parenteral, topical and inhalation dosage forms. Our formulation expertise lies in the areas of taste masking, spray-drying, drug-layering, nano-milling among others. The ability to develop difficult-to-make, complex APIs by using latest technologies is the key differentiating factor of our research.
Some of our features
We're Quality
We produce a comprehensive, diverse and highly complementary portfolio of medicines
Consistency
Endeavour to bring new products to the market & consistently deliver value to stakeholders
Innovation
Implement new ideas & technologies to meet unmet needs and think ahead of times
Reliability
Maintain efficiency & discipline in all processes & systems and fulfil the promises made to stakeholders